The sensor, caught discreetly to his brow, instantly locations him in Silicon Valley’s strangest and most formidable membership: the billionaires making an attempt to out-engineer dying.
Goyal, the CEO of Everlasting (the mother or father firm of Zomato and Blinkit), has spent 2025 shuttling between meals supply, fast commerce and a brand new slate of experiments. Now, he’s making a sharper pivot into deeptech and longevity. With Temple — a wearable designed to trace mind blood circulation in actual time — Goyal turns into the newest tech founder to wager that ageing is just a technical drawback ready for an answer.
He’s hardly alone. Conversations about residing previous 100 have moved from science fiction into geopolitics, with China’s Xi Jinping and Russia’s Vladimir Putin getting caught on sizzling mic speaking about residing to 150 earlier this yr. And for greater than a decade, tech leaders have been pouring cash into extending human lifespan.
Goyal’s entry marks India’s most high-profile addition to a worldwide motion dominated up to now by US tech founders.
However why are so many tech entrepreneurs — not conventional pharma giants — driving this area?
Additionally Learn: Stanford researchers construct a brain-computer that may learn your ideas, but it surely wants a ‘thoughts password’ first. This is the way it works
Why tech founders suppose they will hack dying
In contrast to Massive Pharma, tech billionaires include a really totally different worldview: Loss of life is an engineering drawback, not future.
Peter Thiel, who has backed Unity Biotechnology and the Methuselah Basis, as soon as instructed Enterprise Insider (2012): “There are all these individuals who say that dying is pure… nothing might be farther from the reality.”
They’re wired for moonshots. They constructed software program that scaled to billions; now they’re framing biology, cognition and ageing the identical means — as methods that may be optimised.
They’ll afford to attend. Longevity analysis takes many years. Tech founders have each the capital and the persistence to make long-horizon bets.
There’s additionally actual cash to be made. As early as 2019, Financial institution of America projected the anti-aging and longevity trade may hit $600 billion by 2025, pushed by genomics, AI well being, “ammortality” tech and moonshot medication. Genomics alone, BofA mentioned, might be a $41 billion market by 2025.
They see a species-level transformation. OpenAI’s Sam Altman — who put $180 million into Retro Biosciences so as to add a decade to human lifespan — instructed Enterprise Insider that longevity wants an “OpenAI-type effort.”
It’s tech’s attribute mixture of hubris and idealism: the idea that they will reprogramme life itself.
The worldwide longevity membership
The solid is now acquainted:
Jeff Bezos is reportedly backing Altos Labs, which goals to reverse illness via mobile rejuvenation.
Peter Thiel has spent tens of millions on anti-aging medicine, regenerative medication, and cryonics.
Larry Ellison funneled over $430 million in grants to ageing analysis via the Ellison Medical Basis earlier than 2013.
Larry Web page constructed Calico Labs in 2013, now seen as a precursor to Altos.
Sergey Brin has spent greater than $1 billion on Parkinson’s analysis and helped spin out Alphabet’s Verily Life Sciences.
Mark Zuckerberg and Priscilla Chan based the Breakthrough Prize and dedicated tens of millions to life-sciences analysis via CZI.
Bryan Johnson, maybe the poster little one of biohacking, has slowed his “organic age” via a $2 million-a-year routine.
It’s a mixture of institutional ventures, moonshot labs and a tradition of maximum self-experimentation.
Additionally Learn: Apple to develop brain-computer interface, following path laid by Elon Musk’s Neuralink
Temple: Deepinder Goyal’s entry into brain-tech
The brand new wearable, teased in December, goals to trace mind blood circulation repeatedly.
Goyal additionally clarified that Temple isn’t a part of Everlasting — suggesting he sees it as a standalone deeptech enterprise.
Temple aligns with a worldwide increase in brain-computer interfaces (BCIs). In response to a World Financial Discussion board report from 2024, almost 700 corporations worldwide at the moment are concerned in BCI analysis. The market is projected to hit $6.2 billion by 2030.
The BCI gold rush
A lot of the thrill comes from Neuralink, Elon Musk’s brain-implant startup — valued at $9 billion — which has sparked a race within the area.
Neuralink is pushing towards shopper functions, not simply medical ones. It goals to implant a tool in a wholesome individual by 2030, Bloomberg reported earlier this yr.
It’s planning a brand new trial to learn speech instantly from the mind.
The corporate imagines interfacing instantly with AI fashions “on the velocity of thought.”
BCIs are now not confined to paralysis therapy or analysis labs. Gaming, psychological wellness, neuro-marketing and adaptive studying at the moment are rising use circumstances.
And India — with rising startups and now Goyal’s Temple — is starting to register on that international map.
Additionally Learn: Elon Musk’s Neuralink faucets FDA regulator who led division overseeing the startup
Why this second issues
The convergence of longevity science, AI, neuroscience and personal-tech {hardware} is collapsing beforehand separate industries. A tech billionaire coming into deeptech was as soon as a curiosity. Right this moment it’s virtually anticipated.
India is now pushing aggressively into semiconductors, aerospace and biotech. The BCI and longevity markets are increasing quickly.
And international curiosity in extending human lifespan has gone from dinner-table debate to geopolitical precedence.
The massive query
Whether or not these bets will ship something near age reversal or mind-to-machine communication is unclear.
However the ambition is unmistakable: a future the place residing to 120 is regular, the place illness is engineered away, and the place human cognition meshes seamlessly with machines.
That future might take many years. However for tech founders like Goyal, Bezos, Altman and Thiel, many years are precisely the timelines they’re betting on.
Leave a Reply